Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Economic Burden
100%
Population-based Study
100%
Cirrhosis
100%
Viral Hepatitis
66%
Longitudinal Analysis
66%
Treatment Burden
66%
Non-alcoholic Fatty Liver Disease (NAFLD)
63%
Hepatitis C Virus
54%
Health Planning
40%
Health Development
40%
Hospital Charges
39%
Cirrhotic Patients
34%
Health Care Reform
33%
Legal Restrictions
33%
Entecavir
33%
Lower GI Bleeding
33%
Safety-net Hospital
33%
Chronic Hepatitis C Infection
33%
Non-response
33%
Proton Pump Inhibitors
33%
High Mortality
33%
Adverse Effects
33%
Hepatitis B Virus
33%
Suboptimal Response
33%
Inpatient Costs
33%
Interferon-α (IFN-α)
33%
Probability of Line of Sight (PLoS)
33%
Acute Respiratory Illness
33%
Inpatient Admission
33%
Chronic Hepatitis B Patients
33%
Inpatient Mortality
33%
Bleeding
22%
Retrospective Analysis
16%
Sustained Viral Suppression
16%
Data Availability Statement
16%
Breach of Contract
16%
Information Services
16%
National Health Database
16%
Adefovir
16%
Financial Function
16%
Patient Privacy
16%
Mortality Rate
15%
Liver Fibrosis Model
13%
Treatment Nonresponder
13%
Untreated Patients
13%
Biochemical Response
13%
Liver Disease Progression
13%
Liver
12%
Cause of Death
12%
Ischemic Colitis
11%
Medicine and Dentistry
Liver Cirrhosis
100%
Health Care
66%
Nonalcoholic Fatty Liver
50%
Health Care Cost
50%
Health Planning
37%
Hepatitis Virus
33%
Respiratory Disease
33%
4 Iodo 2,5 Dimethoxyamphetamine
33%
Lower Gastrointestinal Bleeding
33%
Infection
33%
Chronic Hepatitis C
33%
Bleeding
33%
Gastroenterology
33%
Interferon
33%
Proton-Pump Inhibitor
33%
Entecavir
33%
Adverse Event
33%
Hepatitis C Virus
25%
Liver Disease
21%
Mortality Rate
19%
Division
16%
Privacy
16%
Prevalence
15%
Disease Exacerbation
13%
Veterans Affairs
13%
Liver Fibrosis
13%
Malignant Neoplasm
13%
Etiology
12%
Upper Gastrointestinal Bleeding
11%
Angiography
11%
Antiplatelet
11%
Ischemic Colitis
11%
Resuscitation
11%
Anticoagulant Therapy
11%
Angiodysplasia
11%
Colorectal Tumor
11%
Acetylsalicylic Acid
11%
Nonsteroid Antiinflammatory Agent
11%
Triage
11%
Gastrointestinal Endoscopy
11%
Anticoagulant
11%
Diverticulum
11%
Surgical Emergency
11%
Medicare
9%
Diseases
8%
Liver Cancer
8%
Alcohol Liver Disease
8%
Hypergastrinemia
8%
Iron Deficiency
8%
Clinical Management
8%
Nursing and Health Professions
Health Care Policy
100%
Liver Cirrhosis
66%
Healthcare System
50%
Health Care
38%
Safety Net Hospital
33%
Chronic Hepatitis C
33%
Interferon
33%
Health Care Practice
33%
Infection
33%
Hepatitis C
32%
Liver Disease
21%
Public Health Informatics
19%
Treatment Outcome
17%
Nonalcoholic Fatty Liver
16%
Liver Fibrosis
13%
Disease Exacerbation
13%
Etiology
12%
Economic and Social Development
11%
Care Coordination
11%
Hospital Administrator
11%
Technology Integration
8%
Medicaid
8%
Health Care Delivery
8%
Medicare
8%
Health Information Exchange
8%
Cost Control
8%
Community Care
8%
Independent Practice Association
8%
System Analysis
8%
Hypomagnesemia
8%
Overall Survival
6%
University Hospital
6%
Liver Biopsy
6%
Proportional Hazards Model
6%
Teaching Hospital
6%
Clinical Outcome
6%
